LU90657I2 - Ganirelix ou ses sels pharmaceutiquement acceptables - Google Patents

Ganirelix ou ses sels pharmaceutiquement acceptables

Info

Publication number
LU90657I2
LU90657I2 LU90657C LU90657C LU90657I2 LU 90657 I2 LU90657 I2 LU 90657I2 LU 90657 C LU90657 C LU 90657C LU 90657 C LU90657 C LU 90657C LU 90657 I2 LU90657 I2 LU 90657I2
Authority
LU
Luxembourg
Prior art keywords
phe
ala
naphthyl
alkyl
trp
Prior art date
Application number
LU90657C
Other languages
English (en)
Original Assignee
Syntex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Llc filed Critical Syntex Llc
Publication of LU90657I2 publication Critical patent/LU90657I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
LU90657C 1987-02-05 2000-10-18 Ganirelix ou ses sels pharmaceutiquement acceptables LU90657I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/010,923 US4801577A (en) 1987-02-05 1987-02-05 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists

Publications (1)

Publication Number Publication Date
LU90657I2 true LU90657I2 (fr) 2001-01-15

Family

ID=21748050

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90657C LU90657I2 (fr) 1987-02-05 2000-10-18 Ganirelix ou ses sels pharmaceutiquement acceptables

Country Status (22)

Country Link
US (2) US4801577A (fr)
EP (1) EP0277829B1 (fr)
JP (1) JPH0791314B2 (fr)
KR (1) KR930008095B1 (fr)
AT (1) ATE109159T1 (fr)
AU (1) AU614275B2 (fr)
BR (1) BR1100688A (fr)
CA (1) CA1339043C (fr)
DE (2) DE10075027I2 (fr)
DK (1) DK173544B1 (fr)
ES (1) ES2056908T3 (fr)
FI (2) FI92326C (fr)
HK (1) HK35997A (fr)
HU (3) HUT63855A (fr)
IE (1) IE63707B1 (fr)
IL (1) IL85316A (fr)
LU (1) LU90657I2 (fr)
MX (1) MX9202737A (fr)
NL (1) NL300016I2 (fr)
NO (3) NO176440C (fr)
NZ (1) NZ223403A (fr)
ZA (1) ZA88795B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
NZ226557A (en) * 1987-10-15 1990-07-26 Syntex Inc Pharmaceutical compositions for the intranasal administration of a biologically active polypeptide in powder form and process for their preparation
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
US5039660A (en) * 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
WO1990010437A1 (fr) * 1989-03-09 1990-09-20 Endocon, Inc. Pellets de peptides partiellement fondus
US6156731A (en) * 1989-05-10 2000-12-05 G. D. Searle & Co. Polypeptide composition for oral administration
US5232707A (en) * 1989-07-10 1993-08-03 Syntex (U.S.A.) Inc. Solvent extraction process
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
US5212288A (en) * 1990-02-20 1993-05-18 Syntex (U.S.A.) Inc. Temporary minimal protection synthesis of serine-containing polypeptides
EP0477499B1 (fr) * 1990-08-04 1994-01-26 Hoechst Aktiengesellschaft Antagonistes de gonadolibérine
US5783562A (en) * 1990-11-10 1998-07-21 Asta Medica Aktiengesellschaft Luteinizing hormone releasing hormone analogs
CN1036343C (zh) * 1990-11-10 1997-11-05 天津市计划生育研究所 新促黄体生成素释放激素拮抗类似物的制备方法
IL101074A (en) * 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
EP0593491B1 (fr) * 1991-04-25 1996-10-23 DEGHENGHI, Romano Peptides antagonistes de l'hormone de liberation de la luteinostimuline
DE4117507A1 (de) * 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
WO1993003752A1 (fr) * 1991-08-19 1993-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Decapeptide possedant une efficacite de stimulation de la dopamine
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
JPH06510046A (ja) * 1991-08-26 1994-11-10 アボツト・ラボラトリーズ 治療薬の舌下または頬投与のための組成物及び方法
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
US5656727A (en) * 1992-09-15 1997-08-12 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6566330B1 (en) * 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US6043218A (en) * 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
DK0994718T3 (da) 1997-06-20 2005-12-19 Akzo Nobel Nv Gonadotropin releasing hormon-antagonist
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
WO2002056903A2 (fr) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methodes pour traiter des etats lies aux hormones au moyen d'une combinaison d'antagonistes de la lhrh et de modulateurs selectifs des recepteurs des oestrogenes
GB0320806D0 (en) 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
EP2286791B1 (fr) 2003-12-30 2014-03-26 Durect Corporation Implants polymériques, contenant de préférence un mélange de polyéthylène glycol et de polylactide co-glycolide, pour la libération contrôlée de principes actifs
JP5361210B2 (ja) * 2008-02-22 2013-12-04 キヤノン株式会社 樹脂組成物および成形体
CN102584945A (zh) * 2012-02-09 2012-07-18 深圳翰宇药业股份有限公司 一种醋酸加尼瑞克的制备方法
CN104231055A (zh) 2013-06-18 2014-12-24 深圳翰宇药业股份有限公司 加尼瑞克前体以及由其制备醋酸加尼瑞克的方法
CN109443592A (zh) * 2018-09-19 2019-03-08 东华大学 一种温敏嵌段共聚物低临界溶解温度的测定方法
CN111943960B (zh) 2019-07-29 2022-02-15 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
EP4656241A2 (fr) 2021-11-01 2025-12-03 Shandong Luye Pharmaceutical Co., Ltd. Antagoniste de l'hormone de libération de la gonadotrophine, son procédé de préparation et son utilisation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215038A (en) * 1978-10-16 1980-07-29 The Salk Institute For Biological Studies Peptides which inhibit gonadal function
US4419347A (en) * 1980-10-06 1983-12-06 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4481190A (en) * 1982-12-21 1984-11-06 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4667014A (en) * 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
US4581169A (en) * 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
ZA846154B (en) * 1983-08-16 1985-03-27 Akzo Nv Lh-rh antagonists
EP0145032B1 (fr) * 1983-08-16 1987-11-04 Akzo N.V. Antagonistes de LH/RH
US4569927A (en) * 1984-02-23 1986-02-11 The Salk Institute For Biological Studies GnRH Antagonists IV
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
AU2012488A (en) * 1987-07-31 1989-02-02 Syntex (U.S.A.) Inc. Combination therapy with lhrh antagonist analogs and 19nor progestational steroids
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
DE4117507A1 (de) * 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
CA2136079A1 (fr) * 1992-12-18 1994-07-07 Fortuna Haviv Antagonistes de lhrh presentant des residus aminoacyle modifies en position 5 et 6
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5516759A (en) * 1994-12-08 1996-05-14 Tap Holdings Inc. LHRH antagonists having lactam groups at the N-terminus
US5574011A (en) * 1995-04-04 1996-11-12 Tien; Henry C. Compositions and methods for the treatment of male-pattern baldness

Also Published As

Publication number Publication date
NO880494L (no) 1988-08-08
HUT63855A (en) 1993-10-28
IL85316A0 (en) 1988-07-31
US4801577A (en) 1989-01-31
FI880509A0 (fi) 1988-02-04
ES2056908T3 (es) 1994-10-16
FI92326C (fi) 1994-10-25
HK35997A (en) 1997-03-27
NL300016I1 (nl) 2000-11-01
FI930694A0 (fi) 1993-02-17
HUT46340A (en) 1988-10-28
BR1100688A (pt) 2000-04-18
AU1126588A (en) 1988-08-11
FI92326B (fi) 1994-07-15
CA1339043C (fr) 1997-04-01
DK57288A (da) 1988-08-06
IE880298L (en) 1988-08-05
NO922632L (no) 1988-08-08
EP0277829A3 (en) 1990-10-31
IE63707B1 (en) 1995-05-31
EP0277829B1 (fr) 1994-07-27
ATE109159T1 (de) 1994-08-15
DE10075027I2 (de) 2004-07-01
MX9202737A (es) 1992-06-30
ZA88795B (en) 1989-10-25
FI92211B (fi) 1994-06-30
AU614275B2 (en) 1991-08-29
FI92211C (fi) 1994-10-10
NO176440C (no) 1995-04-05
KR930008095B1 (ko) 1993-08-25
DE3850789D1 (de) 1994-09-01
KR890013060A (ko) 1989-09-21
JPS63201199A (ja) 1988-08-19
DK57288D0 (da) 1988-02-04
JPH0791314B2 (ja) 1995-10-04
NO922632D0 (no) 1992-07-03
FI930694A7 (fi) 1993-02-17
IL85316A (en) 1992-07-15
NO880494D0 (no) 1988-02-04
NO176440B (no) 1994-12-27
EP0277829A2 (fr) 1988-08-10
US5767082A (en) 1998-06-16
NO2001001I1 (no) 2001-02-05
NO301014B1 (no) 1997-09-01
FI880509A7 (fi) 1988-08-06
HU215855B (hu) 2001-02-28
DE3850789T2 (de) 1995-03-09
NZ223403A (en) 1990-10-26
DE10075027I1 (de) 2000-11-30
NL300016I2 (nl) 2001-01-02
DK173544B1 (da) 2001-02-19
HU210819A9 (en) 1995-08-28

Similar Documents

Publication Publication Date Title
LU90657I2 (fr) Ganirelix ou ses sels pharmaceutiquement acceptables
DK395688D0 (da) Lhrh-antagonister, deres fremstilling og laegemidler der indeholder dem
ES2060035T3 (es) Aislamiento y elucidacion estructural de los depsipeptidos citostaticos lineales dolastatina 13 y deshidrodolastatina 13.
PT788509E (pt) Derivados peptidicos terapeuticos
ES8604265A1 (es) Un metodo para preparar un peptido o una sal no toxica del mismo.
EA199800230A1 (ru) Тетрагидрохинолины в качестве антагонистов nmda (n-метил-d-аспарагиновой кислоты)
SE9101838D0 (sv) Novel peptides and their use
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
DE60032600D1 (de) Spermin:peptidhaltige tenside
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
GB1294771A (en) Thyrocalcitonin derivative
EA200101106A1 (ru) Фармацевтический комплекс
SE9002384D0 (sv) Derivat av baklobshormoner
IT1317885B1 (it) Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
FI933629L (fi) Antagonistpeptider till hormon som frigoer luteiniserande hormon (lhrh)
NO930016L (no) Derivater av hypofysens baklapphormoner